Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : lcav -- Ignore unavailable to you. Want to Upgrade?

To: Harry W. Lowe who wrote (106)	12/5/1997 9:33:00 PM
From: Jim Mac	Read Replies (1) \| Respond to of 942

For a glimpse of what can happen with a fixed-site-only strategy, check out Beacon Eye Centers. They're an LCAV clone, and they're burning lots of cash while their procedure growth lags that of LVCI, which is rapidly blanketing the country with access sites. LVCI has only about 5% of all U.S. lasers, but provides 20% of all access sites, thanks to its mobile strategy. LCAV, on the other hand, has maybe 9% of all U.S. lasers, but provides only 9% of access sites. LCAV is creeping toward profitability, while LVCI is racing there. LVCI's U.S. operations turned cash flow positive in October, in November company turned EBITDA positive, and they're growing faster than anyone else, with a likely profitability date of April 1998 or sooner. On top of that, LVCI gets to keep ALL of their profit, unlike LCAV, which will be giving away 20% to Summit. Not a good deal.